Currently out of the existing stock ratings of James Gordon, 23 are a BUY (36.51%), 38 are a HOLD (60.32%), 2 are a SELL (3.17%).

James Gordon

Work Performance Price Targets & Ratings Chart

Analyst James Gordon, currently employed at BAML, carries an average stock price target met ratio of 62.65% that have a potential upside of 30.82% achieved within 209 days.

James Gordon’s has documented 125 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARGX, argenx NV ADR at 03-Nov-2024.

Wall Street Analyst James Gordon

Analyst best performing recommendations are on GRFS (GRIFOLS SA ADR).
The best stock recommendation documented was for GRFS (GRIFOLS SA ADR) at 1/3/2023. The price target of $9.09 was fulfilled within 1 day with a profit of $0.35 (4%) receiving and performance score of 40.05.

Average potential price target upside

of $91.03 (23.81%) on ARGX (ARGENX NV ADR).
of $9.39 (14.89%) on GLPG (GALAPAGOS NV ADR).
of $5.93 (134.05%) on MOR (MORPHOSYS AG ADR).

ALC Alcon AG ARGX argenx NV ADR GLPG Galapagos NV ADR GMAB Genmab AS GSK GlaxoSmithKline PLC ADR GRFS Grifols SA ADR MOR MorphoSys AG ADR AZN AstraZeneca PLC ADR ABCM Abcam PLC

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Christoph Gretler (CREDIT SUISSE)